These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31059986)

  • 1. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier.
    McLenachan S; Zhang D; Zhang X; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Fletcher S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101357. PubMed ID: 30611018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
    Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
    Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
    Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200.
    Zhang D; McLenachan S; Chen SC; Zaw K; Alziyadat Y; Zhang X; Lamey TM; Thompson JA; McLaren TL; Mellough C; De Roach JN; Chen FK
    Stem Cell Res; 2021 Mar; 51():102154. PubMed ID: 33429167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
    Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1.
    Ferraro RM; Lanzi G; Masneri S; Barisani C; Piovani G; Savio G; Cattalini M; Galli J; Cereda C; Muzi-Falconi M; Orcesi S; Fazzi E; Giliani S
    Stem Cell Res; 2019 Dec; 41():101580. PubMed ID: 31644995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.